IQWiG examines added benefit of belimumab for patients with systemic lupus erythematosus
00:58 EDT 30 Aug 2012 | The Medical News
Belimumab has been approved since July 2011 as an add-on therapy for adult patients with the autoimmune disease systemic lupus erythematosus (SLE). Products (AMNOG).
Original Article: IQWiG examines added benefit of belimumab for patients with systemic lupus erythematosus
More From BioPortfolio on "IQWiG examines added benefit of belimumab for patients with systemic lupus erythematosus"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
